Literature DB >> 14602216

MHC class II alleles in Mexican patients with rheumatic heart disease.

Guadalupe Hernández-Pacheco1, José Aguilar-García, Carmina Flores-Domínguez, José Manuel Rodríguez-Pérez, Nonanzit Pérez-Hernández, Edith Alvarez-Leon, Pedro A Reyes, Gilberto Vargas-Alarcón.   

Abstract

BACKGROUND: Rheumatic heart disease (RHD) is an autoimmune sequel of group A streptococcal infection that has been associated with the presence of some major histocompatibility complex (MHC) genes. Thus, the aim of the present study was to investigate the role of class II alleles in the genetic susceptibility to RHD in Mexican patients and establish the relationship of these alleles with the pattern of valve damage.
METHODS: HLA-DR, -DQA1 and -DQB1 allele frequencies were determined by PCR-SSO reverse dot blot and PCR-SSP in 98 Mexican Mestizo patients with RHD and 99 healthy controls. Patients were divided into mitral valve damage (n=46), multivalvular lesion (n=49) and aortic damage (n=3).
RESULTS: RHD patients presented an HLA-DR16 increased frequency (pC=0.009, OR=3.9) and a decreased HLA-DR11 frequency (pC=0.018) when compared to healthy controls. HLA-DR16 subtyping showed that DRB1*1602 was the DR16 allele increased in patients (pC=0.007, OR=5.3). Haplotype analysis showed increased frequency of DR16-DQA1*0501-DQB1*0301 in RHD patients when compared to healthy controls (pC=0.011). HLA-DR16 frequency remained significantly increased on patients with multivalvular lesion (pC=0.004, OR=4.8).
CONCLUSIONS: Our data suggest an important participation of Amerindian autochthonous HLA-DR16 (DRB1*1602) allele and DR16-DQA1*0501-DQB1*0301 haplotype as markers for RHD genetic susceptibility in the Mexican Mestizo population. HLA-DR16 allele could also play an important role in determining the pattern of valve damage on these patients.

Entities:  

Mesh:

Year:  2003        PMID: 14602216     DOI: 10.1016/s0167-5273(03)00040-8

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

Review 1.  The clinical and diagnostic significance of anti-myosin autoantibodies in cardiac disease.

Authors:  Udi Nussinovitch; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

Review 2.  Acute rheumatic fever and rheumatic heart disease.

Authors:  Jonathan R Carapetis; Andrea Beaton; Madeleine W Cunningham; Luiza Guilherme; Ganesan Karthikeyan; Bongani M Mayosi; Craig Sable; Andrew Steer; Nigel Wilson; Rosemary Wyber; Liesl Zühlke
Journal:  Nat Rev Dis Primers       Date:  2016-01-14       Impact factor: 52.329

3.  No association of PTPN22 R620W gene polymorphism with rheumatic heart disease and systemic lupus erythematosus.

Authors:  Rahime Aksoy; Türker Duman; Onur Keskin; Nurşen Düzgün
Journal:  Mol Biol Rep       Date:  2011-03-08       Impact factor: 2.316

Review 4.  Cutting edge issues in rheumatic fever.

Authors:  Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

5.  The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease.

Authors:  Michael D Seckeler; Tracey R Hoke
Journal:  Clin Epidemiol       Date:  2011-02-22       Impact factor: 4.790

Review 6.  The Genetic Control of the Rheumatic Heart: Closing the Genotype-Phenotype Gap.

Authors:  Atiyeh M Abdallah; Marawan Abu-Madi
Journal:  Front Med (Lausanne)       Date:  2021-03-24

7.  Gene polymorphisms of TNF-alpha(-308), IL-10(-1082), IL-6(-174), and IL-1Ra(VNTR) related to susceptibility and severity of rheumatic heart disease.

Authors:  A Settin; H Abdel-Hady; R El-Baz; I Saber
Journal:  Pediatr Cardiol       Date:  2007-06-29       Impact factor: 1.838

8.  HLA class II DR and DQ genotypes and haplotypes associated with rheumatic fever among a clinically homogeneous patient population of Latvian children.

Authors:  Valda Stanevicha; Jelena Eglite; Dace Zavadska; Arturs Sochnevs; Ruta Shantere; Dace Gardovska
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

9.  Rheumatic heart disease in Uganda: the association between MHC class II HLA DR alleles and disease: a case control study.

Authors:  Emmy Okello; Andrea Beaton; Charles K Mondo; Paul Kruszka; Noah Kiwanuka; Richard Odoi-Adome; Juergen Freers
Journal:  BMC Cardiovasc Disord       Date:  2014-02-28       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.